Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Rosetta Guidance and Awareness Services for Independent Living

ROSETTA

The objective of ROSETTA is to help community dwelling people with progressive chronic disabilities, such as Alzheimer’s Disease, to retain their autonomy and quality of life as much as possible and to support their (in)formal carers by developing and providing an ICT system that offers activity guidance and awareness services for independent...

Funding Programme
Start Date
End Date
Total Funding
€ 3 273 350
European Countries Involved

Small molecule stabilizers of 14-3-3 Protein-Protein Interactions as novel drugs in cancer and neurodegenerative diseases

14-3-3Stabs

The objective of the application is the development and characterization of small molecule stabilizers of protein-protein interactions (“Molecular Glues”) as a novel class of biological tool compounds and potential therapeutic drugs for the treatment of cancer as well as Alzheimer’s and Parkinson’s Disease, respectively. As biological targets we...

Funding Programme
Start Date
End Date
Total Funding
€ 2 008 622
European Countries Involved

Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia

SVDs-at-target

Stroke and dementia rank among the most pressing health issues in Europe. Cerebral small vessel diseases (SVDs) have emerged as a central link between these two major co-morbidities. SVDs account for more than 30% of strokes and at least 40% of dementia cases. They encounter multiple distinct diseases that can be separated based on their underlying...

Funding Programme
Start Date
End Date
Total Funding
€ 5 998 300
European Countries Involved

Social Interactive Care System  to support the well-being of people living with dementia (Many-Me)

Many-Me

The main objective of Many-Me is to offer patients in different stages of dementia a friendly and enjoyable environment supported by ICT solutions, empowering them to self-manage their condition by engaging and learning from people in a similar situation, make friends and attend support groups, test and adopt routines or techniques that help memory...

Funding Programme
Start Date
End Date
Total Funding
€ 2 400 000
European Countries Involved

Social Health And Reserve in the Dementia patient journey

SHARED

The role of social health in onset, disease course and prognosis of dementia remains underexplored. Social health has been conceptualized as the influence of social resources in finding a balance between capacities and limitations. Moreover, social health affects and is affected by biological processes that underlie the dementia syndrome. This...

Funding Programme
Start Date
End Date
European Countries Involved

Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions

SMASH-HCM

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease (prevalence 1:200 - 1:500), manifested by thickening of cardiac walls, increasing risks of arrhythmia, and sudden cardiac death. HCM affects all ages - it is the leading cause of death among young athletes. Comorbidities due to gene mutations include altered vascular...

Funding Programme
Start Date
End Date
Total Funding
€ 8 546 366
European Countries Involved

Subjective cognitive decline in preclinical Alzheimer’s Disease: European initiative on harmonization and on a lifestyle-based prevention strategy

EURO-SCD

Subjective cognitive decline (SCD) in elderly individuals with still normal cognitive performance is considered an at-risk condition of Alzheimer's disease (AD) dementia and may reflect its first symptomatic manifestation. This makes SCD a promising target for dementia prevention trials. This project aims at creating a transnational, harmonized...

Funding Programme
Start Date
End Date
Total Funding
€ 834 697
European Countries Involved

SUstainable PROduction of GALanthamine by both in vitro and agricultural crops of highly galanthamine-containing plants

SUPROGAL

Galanthamine is an alkaloid produced exclusively by plants of the family Amaryllidaceae, mainly belonging to the genus Galanthus, Leucojum and Narcissus. Owing to its acetylcholinesterase inhibitory activity, galanthamine is used and marketed for the treatment of the Alzheimer’s disease, among others. Although it is obtained by organic synthesis...

Funding Programme
Start Date
End Date
Total Funding
€ 1 343 680
European Countries Involved

Targeting epigenetic dysregulation in the brainstem in Alzheimer’s disease

EPI-AD

We aim to elucidate the exact role of epigenetic dysregulation in the brainstem in the pathogenesis of AD. For this purpose, we will examine post-mortem brainstem tissue derived from AD patients, and matched controls, for epigenetic differences. By investigating AD-specific epigenetic profiles in the blood of individuals suffering from Mild...

Funding Programme
Start Date
End Date
European Countries Involved

TArgeting Multiphosphorylated tau in Blood for non-invasive Alzheimer's Disease diagnosis and staging

TAMBO-AD

Alzheimer's disease (AD) is the major cause of dementia. The disease has an escalating impact on public health due to an increasing prevalence among the aging population in Europe and globally. In light of the first disease-modifying therapies becoming available, early diagnosis and precise disease staging are crucial for timely implementation of...

Funding Programme
Start Date
End Date
Total Funding
€ 217 076
European Countries Involved

Technology driven self-management for building resilience among people with early stage cognitive impairment

Resilien-T

Many elderly people suffer from one or another Mild Cognitive Impairment (PwMCI). Among many is forgetfulness which may or may not progress to dementia. They are faced with doubt, worry and diminishing self-worth while often being afraid to look for help. We will develop RESILIEN-T to act as a coach to improve the PwMCI self-management in different...

Funding Programme
Start Date
End Date
Total Funding
€ 0
European Countries Involved

The biofabrication of a 3D in vitro human oviduct model to study infertility and factors affecting embryo development

OviChip

Despite being viewed as a simple transport conduit, the oviduct can determine a successful pregnancy and has a life-long impact on our health and wellbeing. Also called the fallopian tube, our understanding of tubal function remains limited, owing to the ethical limitations of human studies and the poor translations of animal studies to people. The...

Funding Programme
Start Date
End Date
Total Funding
€ 2 318 530
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).